Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms
| Autor: | Mads Nielsen, Marco Loog, P.C. Pettersen, Claus Christiansen, Jakob Raundahl, László B. Tankó |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Hormone Replacement Therapy medicine.medical_treatment Hormone replacement Administration Oral Promegestone Trimegestone chemistry.chemical_compound Risk Factors Post-hoc analysis Humans Medicine Breast Breast density Administration Intranasal Progesterone Aged Randomized Controlled Trials as Topic Retrospective Studies Dose-Response Relationship Drug Estradiol business.industry Computer based Obstetrics and Gynecology Estrogens Hormone replacement therapy (menopause) General Medicine Middle Aged Micronized progesterone Postmenopause chemistry Female Active treatment Radiology Progestins business Mammography |
| Zdroj: | Climacteric. 11:135-143 |
| ISSN: | 1473-0804 1369-7137 |
| DOI: | 10.1080/13697130801930385 |
| Popis: | First, to compare the impact of nasally and orally dosed estradiol on breast density; second, to investigate the utility of computer-based automated approaches to the assessment of breast density with reference to traditional methods.Digitized images from two 2-year, randomized, placebo-controlled trials formed the basis of the present post hoc analysis. Active treatments were 1 mg estradiol continuously combined with 0.125 mg trimegestone (oral hormone replacement therapy, HRT) or low-dose (150 or 300 microg estradiol) nasal estradiol cyclically combined with 200 mg micronized progesterone (nasal HRT). The effects on breast density were assessed by a radiologist, providing the BI-RADS score and the interactive threshold, and by a computer-based approach, providing the measure of stripiness and the HRT-effect specific measure of breast density.In the oral HRT trial, active treatment induced a significant increase in breast density, which was consistent in all methods used (all p0.05). In contrast, none of the methods detected significant changes in women receiving nasal HRT. The sensitivity of automated methods to discriminate HRT- from placebo-treated women was equal or better than the sensitivity of methods performed by the radiologist.The markedly different pharmacokinetic profile of nasal estrogen seems to be associated with better breast safety. Automated computer-based analysis of digitized mammograms provides a sensitive measure of changes in breast density induced by hormones and could serve as a useful tool in future clinical trials. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |